Search Results - "Gadaleta, Gennaro"

Refine Results
  1. 1

    Chronic Inflammation in Obesity and Cancer Cachexia by Divella, Rosa, Gadaleta Caldarola, Gennaro, Mazzocca, Antonio

    Published in Journal of clinical medicine (14-04-2022)
    “…Chronic inflammation has long been linked to obesity and related conditions such as type 2 diabetes and metabolic syndrome. According to current research, the…”
    Get full text
    Journal Article
  2. 2

    First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges by Rizzo, Alessandro, Ricci, Angela Dalia, Gadaleta-Caldarola, Gennaro, Brandi, Giovanni

    “…Immunotherapy has recently taken on an extremely important role in medical oncology, as first- or later-line treatment in several tumor types, and recent years…”
    Get more information
    Journal Article
  3. 3

    Lenvatinib plus pembrolizumab: the next frontier for the treatment of hepatocellular carcinoma? by Rizzo, Alessandro, Dadduzio, Vincenzo, Ricci, Angela Dalia, Massari, Francesco, Di Federico, Alessandro, Gadaleta-Caldarola, Gennaro, Brandi, Giovanni

    Published in Expert opinion on investigational drugs (03-04-2022)
    “…While sorafenib monotherapy represented the mainstay of medical treatment for advanced hepatocellular carcinoma (HCC) patients for more than a decade, novel…”
    Get more information
    Journal Article
  4. 4

    Ampullary Carcinoma: An Overview of a Rare Entity and Discussion of Current and Future Therapeutic Challenges by Rizzo, Alessandro, Dadduzio, Vincenzo, Lombardi, Lucia, Ricci, Angela Dalia, Gadaleta-Caldarola, Gennaro

    Published in Current oncology (Toronto) (01-09-2021)
    “…Ampullary carcinomas (ACs) represent a rare entity, accounting for approximately 0.2% of all gastrointestinal solid tumors and 20% of all periampullary cancers…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Mediterranean Lifestyle to Contrast Low-Grade Inflammation Behavior in Cancer by Divella, Rosa, Marino, Graziella, Infusino, Stefania, Lanotte, Laura, Gadaleta-Caldarola, Gaia, Gadaleta-Caldarola, Gennaro

    Published in Nutrients (29-03-2023)
    “…A healthy diet and an active lifestyle are both effective ways to prevent, manage, and treat many diseases, including cancer. A healthy, well-balanced diet not…”
    Get full text
    Journal Article
  7. 7

    Current and Future Role of Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: Which Way to Go Forward by Rizzo, Alessandro, Cusmai, Antonio, Gadaleta-Caldarola, Gennaro, Palmiotti, Gennaro

    Published in Medicina (Kaunas, Lithuania) (27-04-2022)
    “…Immunotherapy has revolutionized previous triple-negative breast cancer (TNBC) treatment algorithms, prompting researchers and clinicians to consider the…”
    Get full text
    Journal Article
  8. 8

    Pemigatinib in Intrahepatic Cholangiocarcinoma: A Work in Progress by Gadaleta-Caldarola, Gennaro, Rizzo, Alessandro, Dadduzio, Vincenzo, Lombardi, Lucia, Gadaleta-Caldarola, Arianna, Infusino, Stefania, Cusmai, Antonio, Citrigno, Claudia, Palmiotti, Gennaro

    Published in Current oncology (Toronto) (01-10-2022)
    “…Cholangiocarcinoma (CCA) is the second most frequent primary liver cancer, following hepatocellular carcinoma (HCC). Progress in the molecular understanding of…”
    Get full text
    Journal Article
  9. 9

    Synergizing Immunotherapy and Antibody-Drug Conjugates: New Horizons in Breast Cancer Therapy by Pinto, Antonello, Guarini, Chiara, Giampaglia, Marianna, Sanna, Valeria, Melaccio, Assunta, Lanotte, Laura, Santoro, Anna Natalizia, Pini, Francesca, Cusmai, Antonio, Giuliani, Francesco, Gadaleta-Caldarola, Gennaro, Fedele, Palma

    Published in Pharmaceutics (29-08-2024)
    “…The advent of immunotherapy and antibody-drug conjugates (ADCs) have revolutionized breast cancer treatment, offering new hope to patients. However,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Paziente con carcinoma mammario oligometastatico HER2-positivo, lungosopravvivente in trattamento con lapatinib/ capecitabina dopo resezione e termoablazione polmonare by Gadaleta-Caldarola, Gennaro

    Published in Aboutopen (29-12-2017)
    “…In una paziente HER2-positiva in post-menopausa, con metastasi polmonare e linfonodali mediastiniche, il trattamento di mantenimento con lapatinib +…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Which role for predictors of response to immune checkpoint inhibitors in hepatocellular carcinoma? by Rizzo, Alessandro, Cusmai, Antonio, Gadaleta-Caldarola, Gennaro, Palmiotti, Gennaro

    “…Hepatocellular carcinoma (HCC) remains a frequently diagnosed malignancy worldwide, still representing an important cause of cancer-related death. Recent years…”
    Get more information
    Journal Article